(HealthDay)—Domperidone is well tolerated and effective in producing a moderate short-term increase in expressed breast milk volume among mothers of preterm infants, according to a review published online Feb. 22 in BJOG: An International Journal of Obstetrics and Gynaecology.
Luke E. Grzeskowiak, Ph.D., from the University of Adelaide in Australia, and colleagues conducted a literature review to identify randomized controlled trials that compared domperidone with placebo in mothers of preterm infants (<37 weeks' gestation) experiencing insufficient milk supply.
The researchers identified five trials consisting of 194 women. Pooled analysis showed a moderate increase in breast milk volume of 88.3 mL/day with the use of domperidone versus placebo. Maternal adverse events were similar between the groups (odds ratio, 1.05; 95 percent confidence interval, 0.65 to 1.71), with no reported cases of prolonged QTc syndrome or sudden cardiac death.
"Domperidone is well tolerated and results in a moderate short-term increase in expressed breast milk volume among mothers of preterm infants previously identified as having insufficient breast milk supply," the authors write.
Full Text (subscription or payment may be required)
Journal information: BJOG: An International Journal of Obstetrics and Gynaecology
Copyright © 2018 HealthDay. All rights reserved.